by © Sudok1 | Dreamstime.com A trial at Oxford University suggests an existing low cost drug can cut the risk of death from Covid-19 substantially. Tests involving 6,000 hospitalised Covid-19 patients suggest the drug can cut the risk of death for those on ventilators from 40% to 28%. For patients needing oxygen the risk of death ...
Topics:
Investec considers the following as important: 3) Swiss Markets and News, 3.) Health, Coronavirus Switzerland, Covid-19 Switzerland, Editor's Choice, Featured, health, newsletter, SARS-CoV-2 Switzerland, Science and technology
This could be interesting, too:
Investec writes Federal parliament approves abolition of imputed rent
Nachrichten Ticker - www.finanzen.ch writes Krypto-Ausblick 2025: Stehen Bitcoin, Ethereum & Co. vor einem Boom oder Einbruch?
Per Bylund writes Bitcoiners’ Guide to Austrian Economics
Connor O'Keeffe writes The Establishment’s “Principles” Are Fake
© Sudok1 | Dreamstime.com
A trial at Oxford University suggests an existing low cost drug can cut the risk of death from Covid-19 substantially.
Tests involving 6,000 hospitalised Covid-19 patients suggest the drug can cut the risk of death for those on ventilators from 40% to 28%. For patients needing oxygen the risk of death could be cut from 25% to 20%.
The findings are potentially the biggest breakthrough in Covid-19 treatment so far. Lead researcher Prof Martin Landray told the BBC that the findings suggested one life could be saved for every eight patients on a ventilator and one for every 20-25 treated with oxygen.
The drug, dexamethasone, is a steroid treatment that calms the immune response. A course of the globally available drug costs around £35.
However, the drug does not seem to help those with milder symptoms who do not need help breathing.
You Might Also Like
Coronavirus: WHO changes advice on masks
The World Health Organization (WHO) recently changed its advice on face masks. It now recommends healthy people wear them in public when social distancing is not possible, stating that they could provide a barrier for potentially infectious droplets.
Coronavirus: the rising number of mild cases with symptoms lasting months
Those with mild Covid-19 symptoms are supposed to recover after two weeks. However, a rising number of relatively young people with mild cases report symptoms months later. Johns Hopkins Medicine says that those with mild cases of COVID-19 appear to recover within one to two weeks. For severe cases, recovery may take six weeks or more.
Coronavirus: latest antibody study suggests 10.8 percent of Geneva infected in first wave
A recently published update to the ongoing study in Geneva to assess the extent of SARS-CoV-2 infection suggests 10.8% of the population may have been infected in the first wave of infections. The study, which tests a sample of the population over time for IgG SARS-CoV-2 antibodies, started in early April 2020. The latest figures come from the fifth week of testing, which was concluded on 9 May 2020.
Coronavirus: the age difference behind lower Swiss death rate
Switzerland’s Covid-19 death rate has been lower than much of the rest of Europe. A lower infection rate among older people appears to be one reason. The rates of deaths among those either recovering or dying have been particularly high in Belgium (40%), France (34%) and Italy (31%).
Coronavirus: the dangers of singing
As Switzerland reopens, the details around how SARS-CoV-2 spreads becomes more relevant to everyday life. Matthias Egger, the head of Switzerland’s Covid-19 task force, stresses the importance of continuing to follow social distancing and hygiene rules.
Swiss government reveals more on Covid-19 tracing app
On 13 May 2020, Switzerland’s government published more information on the Swiss Proximity Tracing App (Swiss PT), an app designed to slow the spread of SARS-CoV-2. Developed by teams at EPFL and ETHZ, the app uses Bluetooth to detect when your phone comes within two metres of another phone or device with the app. It then records the contact as an anonymous key and the duration of contact, flagging any close contact longer than 15 minutes.
Is the lack of inflight social distancing on SWISS airlines a risk?
Over two days last week, Thailand reported a score of new coronavirus cases. All were Thai nationals returning by air from the Middle East. Otherwise, there have been almost no new community or ‘inside country’ cases since mid-May.
Coronavirus: Switzerland to reopen borders with EU, EFTA and UK on 15 June
Switzerland recently announced that it will lift existing entry restrictions with all EU and EFTA nations and the UK on 15 June 2020. In mid-May the Swiss government announced plans to fully reopen borders with France, Germany and Austria. On 2 June 2020, it decided to hold off on a full reopening of borders with Italy despite Italy’s decision to fully reopen its borders with Switzerland on 3 June 2020.
Tags: Coronavirus Switzerland,Covid-19 Switzerland,Editor's Choice,Featured,Health,newsletter,SARS-CoV-2 Switzerland,Science and technology